Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
274
-
Total 13F shares, excl. options
-
91,971,894
-
Shares change
-
-3,114,116
-
Total reported value, excl. options
-
$1,505,006,212
-
Value change
-
-$51,986,093
-
Put/Call ratio
-
37%
-
Number of buys
-
106
-
Number of sells
-
-127
-
Price
-
$16.38
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q3 2021
333 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q3 2021.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 274 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 91,971,894 shares
.
Largest 10 shareholders include ARK Investment Management LLC (13,501,650 shares), GLENVIEW CAPITAL MANAGEMENT, LLC (8,102,119 shares), PRICE T ROWE ASSOCIATES INC /MD/ (5,518,932 shares), MACQUARIE GROUP LTD (4,697,123 shares), BANK OF AMERICA CORP /DE/ (4,067,496 shares), Parametric Portfolio Associates LLC (4,003,155 shares), Mondrian Investment Partners LTD (3,703,404 shares), CITIGROUP INC (2,869,718 shares), GOLDMAN SACHS GROUP INC (2,534,519 shares), and NORTHERN TRUST CORP (2,262,834 shares).
This table shows the top 274 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.